Wound Irrigation for Cesarean Section Complications
Trial Summary
What is the purpose of this trial?
This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is wound irrigation generally safe for humans?
Research indicates that solutions like Lavasept and Irriclens (a 0.9% sodium chloride solution) are safe for wound irrigation, showing good tissue compatibility and no evidence of impaired wound healing. Lavasept also has a good anti-inflammatory effect, making it a safe choice for treating wounds.12345
How does the treatment Irrisept differ from other treatments for cesarean section complications?
Irrisept is unique because it is an antimicrobial wound lavage system specifically designed to clean and debride (remove dead tissue from) wounds, which may help reduce infection risk. Unlike other treatments that use saline or povidone-iodine, Irrisept combines irrigation with an antimicrobial agent, potentially offering a more effective approach to preventing wound complications after cesarean sections.26789
Research Team
Ruofan Yao, MD, MPH
Principal Investigator
Loma Linda University
Eligibility Criteria
This trial is for adults over 18 with a single pregnancy planning a cesarean delivery at or after 37 weeks gestation, who will follow up post-op at Loma Linda OBGYN. Participants must speak English or Spanish and have obesity, diabetes, ruptured membranes, or intraamniotic infection. Emergency C-sections are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either normal saline or Irrisept for wound irrigation following cesarean section
Follow-up
Participants are monitored for wound healing using a composite wound evaluation scale
Treatment Details
Interventions
- Irrisept (Antiseptic)
- Normal Saline (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loma Linda University
Lead Sponsor
Irrimax Corporation
Industry Sponsor